- Home
- QGEN vs EVR Comparison
QGEN vs EVR Comparison
Compare QGEN & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- EVR
- Stock Information
- Founded
- QGEN 1986
- EVR 1995
- Country
- QGEN Netherlands
- EVR United States
- Employees
- QGEN N/A
- EVR N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- EVR Investment Managers
- Sector
- QGEN Health Care
- EVR Finance
- Exchange
- QGEN Nasdaq
- EVR Nasdaq
- Market Cap
- QGEN 9.1B
- EVR 8.7B
- IPO Year
- QGEN 1996
- EVR 2006
- Fundamental
- Price
- QGEN $48.08
- EVR $291.68
- Analyst Decision
- QGEN Buy
- EVR Buy
- Analyst Count
- QGEN 8
- EVR 6
- Target Price
- QGEN $50.68
- EVR $274.00
- AVG Volume (30 Days)
- QGEN 1.3M
- EVR 573.5K
- Earning Date
- QGEN 08-05-2025
- EVR 07-23-2025
- Dividend Yield
- QGEN 3.14%
- EVR 1.15%
- EPS Growth
- QGEN N/A
- EVR 63.41
- EPS
- QGEN 0.42
- EVR 10.47
- Revenue
- QGEN $2,002,874,000.00
- EVR $3,094,265,000.00
- Revenue This Year
- QGEN $6.36
- EVR $8.41
- Revenue Next Year
- QGEN $6.18
- EVR $23.58
- P/E Ratio
- QGEN $115.46
- EVR $27.84
- Revenue Growth
- QGEN 3.31
- EVR 27.09
- 52 Week Low
- QGEN $37.63
- EVR $148.63
- 52 Week High
- QGEN $48.90
- EVR $324.06
- Technical
- Relative Strength Index (RSI)
- QGEN 59.71
- EVR 70.98
- Support Level
- QGEN $47.25
- EVR $281.63
- Resistance Level
- QGEN $48.90
- EVR $301.40
- Average True Range (ATR)
- QGEN 0.81
- EVR 7.13
- MACD
- QGEN -0.12
- EVR 1.66
- Stochastic Oscillator
- QGEN 68.98
- EVR 82.37
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About EVR Evercore Inc.
Evercore is an independent investment bank that derives the majority of its revenue from financial advisory, including merger, acquisition, and restructuring advisory. It also has institutional equities trading, equity underwriting, and investment management businesses that account for around 20% of net revenue. The company was founded in 1996 and went public in 2006. Evercore had approximately 2,380 employees at the end of 2024, and about 75% of its revenue is derived from the United States.